Login
Evidence Feed
About
Diagnostics
New
Top genes
FAQ
Contact us
^
Login
Contact us
to learn more about
our Premium Content: News alerts, weekly reports and conference planners
BIOMARKER:
NOTCH1 mutation
i
Other names:
NOTCH1, TAN1
Contact us
to learn more about our Premium Content:
News alerts, weekly reports and conference planners
Entrez ID:
4851
Related biomarkers:
Expression
Mutation
CNA
Others
‹
NOTCH1 mutation + MSI-L/dMMR (1)
NOTCH1 mutation + TMB-L + MSI-L/dMMR (1)
NOTCH1 positive + FGFR2 mutation (1)
NOTCH1 mutation + MSI-L/dMMR (1)
NOTCH1 mutation + TMB-L + MSI-L/dMMR (1)
NOTCH1 positive + FGFR2 mutation (1)
›
Associations
News
Trials
VERI cancer hierarchy
Reset Filters
NOTCH1 mutation
Chronic Lymphocytic Leukemia
NOTCH1 mutation
Chronic Lymphocytic Leukemia
ofatumumab
Resistant: B - Late Trials
ofatumumab
Resistant
:
B
ofatumumab
Resistant: B - Late Trials
ofatumumab
Resistant
:
B
NOTCH1 mutation
Chronic Lymphocytic Leukemia
NOTCH1 mutation
Chronic Lymphocytic Leukemia
obinutuzumab
Resistant: B - Late Trials
obinutuzumab
Resistant
:
B
obinutuzumab
Resistant: B - Late Trials
obinutuzumab
Resistant
:
B
NOTCH1 mutation
Non Small Cell Lung Cancer
NOTCH1 mutation
Non Small Cell Lung Cancer
tislelizumab-jsgr
Sensitive: B - Late Trials
tislelizumab-jsgr
Sensitive
:
B
tislelizumab-jsgr
Sensitive: B - Late Trials
tislelizumab-jsgr
Sensitive
:
B
NOTCH1 mutation
Chronic Lymphocytic Leukemia
NOTCH1 mutation
Chronic Lymphocytic Leukemia
ibrutinib + rituximab + obinutuzumab
Resistant: B - Late Trials
ibrutinib + rituximab + obinutuzumab
Resistant
:
B
ibrutinib + rituximab + obinutuzumab
Resistant: B - Late Trials
ibrutinib + rituximab + obinutuzumab
Resistant
:
B
NOTCH1 mutation
Chronic Lymphocytic Leukemia
NOTCH1 mutation
Chronic Lymphocytic Leukemia
venetoclax + ibrutinib
Sensitive: B - Late Trials
venetoclax + ibrutinib
Sensitive
:
B
venetoclax + ibrutinib
Sensitive: B - Late Trials
venetoclax + ibrutinib
Sensitive
:
B
NOTCH1 mutation
Chronic Lymphocytic Leukemia
NOTCH1 mutation
Chronic Lymphocytic Leukemia
zanubrutinib
Sensitive: B - Late Trials
zanubrutinib
Sensitive
:
B
zanubrutinib
Sensitive: B - Late Trials
zanubrutinib
Sensitive
:
B
NOTCH1 mutation
Non Small Cell Lung Cancer
NOTCH1 mutation
Non Small Cell Lung Cancer
Immunotherapy
Sensitive: C3 – Early Trials
Immunotherapy
Sensitive
:
C3
Immunotherapy
Sensitive: C3 – Early Trials
Immunotherapy
Sensitive
:
C3
NOTCH1 mutation
Chronic Lymphocytic Leukemia
NOTCH1 mutation
Chronic Lymphocytic Leukemia
ibrutinib
Resistant: C3 – Early Trials
ibrutinib
Resistant
:
C3
ibrutinib
Resistant: C3 – Early Trials
ibrutinib
Resistant
:
C3
NOTCH1 mutation
T Acute Lymphoblastic Leukemia
NOTCH1 mutation
T Acute Lymphoblastic Leukemia
prednisone
Sensitive: C3 – Early Trials
prednisone
Sensitive
:
C3
prednisone
Sensitive: C3 – Early Trials
prednisone
Sensitive
:
C3
NOTCH1 mutation
Prolymphocytic Leukemia
NOTCH1 mutation
Prolymphocytic Leukemia
ibrutinib
Resistant: C3 – Early Trials
ibrutinib
Resistant
:
C3
ibrutinib
Resistant: C3 – Early Trials
ibrutinib
Resistant
:
C3
NOTCH1 mutation
Mantle Cell Lymphoma
NOTCH1 mutation
Mantle Cell Lymphoma
ibrutinib
Resistant: C3 – Early Trials
ibrutinib
Resistant
:
C3
ibrutinib
Resistant: C3 – Early Trials
ibrutinib
Resistant
:
C3
NOTCH1 mutation
Diffuse Large B Cell Lymphoma
NOTCH1 mutation
Diffuse Large B Cell Lymphoma
zanubrutinib
Sensitive: C3 – Early Trials
zanubrutinib
Sensitive
:
C3
zanubrutinib
Sensitive: C3 – Early Trials
zanubrutinib
Sensitive
:
C3
NOTCH1 mutation
Diffuse Large B Cell Lymphoma
NOTCH1 mutation
Diffuse Large B Cell Lymphoma
rituximab
Sensitive: C3 – Early Trials
rituximab
Sensitive
:
C3
rituximab
Sensitive: C3 – Early Trials
rituximab
Sensitive
:
C3
NOTCH1 mutation
Colorectal Cancer
NOTCH1 mutation
Colorectal Cancer
sintilimab + fruquintinib
Resistant: C3 – Early Trials
sintilimab + fruquintinib
Resistant
:
C3
sintilimab + fruquintinib
Resistant: C3 – Early Trials
sintilimab + fruquintinib
Resistant
:
C3
NOTCH1 mutation
Adenoid Cystic Carcinoma
NOTCH1 mutation
Adenoid Cystic Carcinoma
tretinoin
Sensitive: C3 – Early Trials
tretinoin
Sensitive
:
C3
tretinoin
Sensitive: C3 – Early Trials
tretinoin
Sensitive
:
C3
NOTCH1 mutation
Chronic Lymphocytic Leukemia
NOTCH1 mutation
Chronic Lymphocytic Leukemia
obinutuzumab + GS-9973
Sensitive: C3 – Early Trials
obinutuzumab + GS-9973
Sensitive
:
C3
obinutuzumab + GS-9973
Sensitive: C3 – Early Trials
obinutuzumab + GS-9973
Sensitive
:
C3
NOTCH1 mutation
Chronic Lymphocytic Leukemia
NOTCH1 mutation
Chronic Lymphocytic Leukemia
venetoclax
Resistant: C3 – Early Trials
venetoclax
Resistant
:
C3
venetoclax
Resistant: C3 – Early Trials
venetoclax
Resistant
:
C3
NOTCH1 mutation
Mantle Cell Lymphoma
NOTCH1 mutation
Mantle Cell Lymphoma
Compound E
Sensitive: D – Preclinical
Compound E
Sensitive
:
D
Compound E
Sensitive: D – Preclinical
Compound E
Sensitive
:
D
NOTCH1 mutation
Triple Negative Breast Cancer
NOTCH1 mutation
Triple Negative Breast Cancer
nirogacestat
Sensitive: D – Preclinical
nirogacestat
Sensitive
:
D
nirogacestat
Sensitive: D – Preclinical
nirogacestat
Sensitive
:
D
NOTCH1 mutation
Squamous Cell Carcinoma of Head and Neck
NOTCH1 mutation
Squamous Cell Carcinoma of Head and Neck
WNT974
Sensitive: D – Preclinical
WNT974
Sensitive
:
D
WNT974
Sensitive: D – Preclinical
WNT974
Sensitive
:
D
NOTCH1 mutation
T Acute Lymphoblastic Leukemia
NOTCH1 mutation
T Acute Lymphoblastic Leukemia
CB-839
Sensitive: D – Preclinical
CB-839
Sensitive
:
D
CB-839
Sensitive: D – Preclinical
CB-839
Sensitive
:
D
NOTCH1 mutation
T Acute Lymphoblastic Leukemia
NOTCH1 mutation
T Acute Lymphoblastic Leukemia
IACS-010759
Sensitive: D – Preclinical
IACS-010759
Sensitive
:
D
IACS-010759
Sensitive: D – Preclinical
IACS-010759
Sensitive
:
D
NOTCH1 mutation
Chronic Lymphocytic Leukemia
NOTCH1 mutation
Chronic Lymphocytic Leukemia
BMF-219
Sensitive: D – Preclinical
BMF-219
Sensitive
:
D
BMF-219
Sensitive: D – Preclinical
BMF-219
Sensitive
:
D
^
^
Full access to predictive biomarker details and heatmap analytics are available with a VERI Account.
Sign up for FREE
Already have an account?
Login
Full access to predictive biomarker details and heatmap analytics are available with a VERI Account.
Sign up for FREE
Already have an account?
Login